Evaluation of the efficacy and safety of injectable glycosaminoglycan-peptide complex (GPC) in patients with osteoarthritis: a multicenter observational study GLADIOLUS (GPC in the treatment of osteoarthritis: a follow-up study of pain relief and local symptom reduction)

Evaluation of the efficacy and safety of injectable glycosaminoglycan-peptide complex (GPC) in patients with osteoarthritis: a multicenter observational study GLADIOLUS (GPC in the treatment of osteoarthritis: a follow-up study of pain relief and local symptom reduction)

Glycosaminoglycan-peptide complex (GPC) is a popular injectable extended-release symptomatic agent (ERSA) in Russia for the treatment of osteoarthritis (OA). To date, no large-scale studies of GPC used in real clinical practice have been conducted in our country.Objective: to evaluate the efficacy a...

Full description

Saved in:
Bibliographic Details
Main Authors: L. I. Alekseeva, A. E. Karateev, E. Yu. Pogozheva, V. N. Amirdzanova, E. S. Filatova, V. A. Nesterenko
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2020-05-01
Series:Современная ревматология
Subjects:
osteoarthritis, glycosaminoglycan-peptide complex
diacerein
nonsteroidal anti-inflammatory drugs
real clinical practice
efficacy
safety
Online Access:https://mrj.ima-press.net/mrj/article/view/1021
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://mrj.ima-press.net/mrj/article/view/1021

Similar Items